The Tel Aviv Stock Exchange fell today. The Tel Aviv 25 Index fell 0.37%, to 1,483.21 points and the Tel Aviv 100 Index fell 0.48%, to 1,271.34 points. The BlueTech Index rose 0.40%, to 323.36 points. The TelBond 20 corporate bond index rose 0.44%, to 314.45 points. Turnover totaled NIS 1.79 billion.
For the week, the Tel Aviv 25 index rose 0.3%. So far this year, the index has fallen 3.0%.
On the foreign exchange market, the representative shekel-dollar rate was set 1.23% lower, at NIS 3.8530/$, and the representative shekel-euro rate was set 0.63% higher, at NIS 4.3521/€.
Two pharmaceuticals stocks led trading and fell steeply: Teva closed off 4.5% and Mylan 6.59%. Pharmaceuticals stocks were affected by the accounting scandal at US company Valeant. Political moves in the US, which could also prompt similar action in Europe, to cut drug prices substantially also weighed on pharma stocks worldwide. Perrigo was another casualty in Tel Aviv, falling 4.42%.
The rest of the leading stocks rose: Bezeq, which reported today, rose 0.6%; Bank Hapoalim rose 0.94%; and Bank Leumi rose 1.8%.
Other notable risers were Gazit Globe, up 4.43%, and Blue Square, up 3.86%. Perion Networks fell a further 4.45%.
Published by Globes [online], Israel business news - www.globes-online.com - on March 17, 2016
© Copyright of Globes Publisher Itonut (1983) Ltd. 2016